- Home
- RCEL vs NMT Comparison
RCEL vs NMT Comparison
Compare RCEL & NMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCEL
- NMT
- Stock Information
- Founded
- RCEL N/A
- NMT 1993
- Country
- RCEL United States
- NMT United States
- Employees
- RCEL N/A
- NMT N/A
- Industry
- RCEL Medical/Dental Instruments
- NMT Finance/Investors Services
- Sector
- RCEL Health Care
- NMT Finance
- Exchange
- RCEL Nasdaq
- NMT Nasdaq
- Market Cap
- RCEL 114.3M
- NMT 107.8M
- IPO Year
- RCEL N/A
- NMT N/A
- Fundamental
- Price
- RCEL $3.91
- NMT $11.53
- Analyst Decision
- RCEL Buy
- NMT
- Analyst Count
- RCEL 5
- NMT 0
- Target Price
- RCEL $11.75
- NMT N/A
- AVG Volume (30 Days)
- RCEL 196.9K
- NMT 19.1K
- Earning Date
- RCEL 11-06-2025
- NMT 01-01-0001
- Dividend Yield
- RCEL N/A
- NMT 3.21%
- EPS Growth
- RCEL N/A
- NMT N/A
- EPS
- RCEL N/A
- NMT N/A
- Revenue
- RCEL $72,401,000.00
- NMT N/A
- Revenue This Year
- RCEL $19.96
- NMT N/A
- Revenue Next Year
- RCEL $33.43
- NMT N/A
- P/E Ratio
- RCEL N/A
- NMT N/A
- Revenue Growth
- RCEL 20.59
- NMT N/A
- 52 Week Low
- RCEL $3.35
- NMT $9.05
- 52 Week High
- RCEL $14.16
- NMT $10.93
- Technical
- Relative Strength Index (RSI)
- RCEL 47.62
- NMT 45.59
- Support Level
- RCEL $3.64
- NMT $11.44
- Resistance Level
- RCEL $4.09
- NMT $11.57
- Average True Range (ATR)
- RCEL 0.25
- NMT 0.08
- MACD
- RCEL 0.06
- NMT -0.00
- Stochastic Oscillator
- RCEL 76.87
- NMT 31.58
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
About NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes and to enhance portfolio value relative to the Massachusetts municipal bond market by investing in tax-exempt Massachusetts municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued.